Randomized Study of IN.PACT Amphirion Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Ischaemia; Restenosis
- Focus Therapeutic Use
- Acronyms INPACT-DEEP
Most Recent Events
- 28 Feb 2018 Biomarkers information updated
- 07 Sep 2012 Planned end date changed from 1 Dec 2015 to 1 Aug 2017 as reported by ClinicalTrials.gov.
- 07 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.